Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07103083 · ClinicalTrials.gov registry record · NA

Postprandial Response to Fruit Juice

A NA study of Blood Glucose and Blood Insulin, sponsored by Ocean Spray Cranberries.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT07103083: Recruiting NA study of Blood Glucose and Blood Insulin, sponsored by Ocean Spray Cranberries.

NCT07103083 is a NA study of Blood Glucose and Blood Insulin that is actively recruiting participants, run by Ocean Spray Cranberries. The registered enrollment target is 18 participants, below the 58-participant average among 4 other Blood Glucose trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07103083, a NA study of Blood Glucose and Blood Insulin, is actively recruiting participants, sponsored by Ocean Spray Cranberries.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine postprandial responses to fruit juices.

Primary Outcome

Glucose incremental area under the curve (iAUC) from pre-product consumption to 120 min

Interventions

  • DIETARY_SUPPLEMENT Beverage 1
  • DIETARY_SUPPLEMENT Beverage 2
  • DIETARY_SUPPLEMENT Beverage 3
  • DIETARY_SUPPLEMENT Beverage 4
  • DIETARY_SUPPLEMENT Beverage 5

Study Locations (1)

Illinois

  • Biofortis Innovation Services - Addison

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2025-07-21
Est. Completion 2025-10-29
Phase NA
Ocean Spray Cranberries

6 total trials

What NCT07103083 shows while recruiting

NCT07103083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 58-participant average among 4 other Blood Glucose trials with a reported enrollment target (69% lower).

The record links to 2 conditions, with Blood Glucose appearing as the primary indexed condition, and to 5 interventions - of which Beverage 1 is the first listed.

NCT07103083 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07103083 about?

NCT07103083 is a clinical study titled "Postprandial Response to Fruit Juice". The goal of this clinical trial is to determine postprandial responses to fruit juices.

What is the current status of trial NCT07103083?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-07-21. Estimated completion is 2025-10-29.

What conditions does trial NCT07103083 study?

This clinical trial studies the following conditions: Blood Glucose, Blood Insulin.

What interventions are being tested in trial NCT07103083?

The interventions under investigation include: Beverage 1 (DIETARY_SUPPLEMENT), Beverage 2 (DIETARY_SUPPLEMENT), Beverage 3 (DIETARY_SUPPLEMENT), Beverage 4 (DIETARY_SUPPLEMENT), Beverage 5 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07103083?

This trial is sponsored by Ocean Spray Cranberries, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07103083 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Glucose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07103083, the US trial registry maintained by the National Library of Medicine. NCT07103083 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.